Editorial comment on: Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
Gratzke
Christian
C
Hedlund
Petter
P
D015415:Biomarkers / Q000378:metabolism; D001707:Biopsy, Needle; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D018031:Connexin 43 / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D014563:Urodynamics; D019459:Urothelium / Q000187:drug effects / Q000378:metabolism
D015415:Biomarkers; D018031:Connexin 43; D019274:Botulinum Toxins, Type A